Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors - PubMed (original) (raw)
. 2013 Jun 11;108(11):2399-406.
doi: 10.1038/bjc.2013.219. Epub 2013 May 7.
M E Jones, D Cunningham, S J Falk, D Gilson, B W Hancock, S J Harris, A Horwich, P J Hoskin, T Illidge, D C Linch, T A Lister, H H Lucraft, J A Radford, A M Stevens, I Syndikus, M V Williams; England and Wales Hodgkin Lymphoma Follow-up Group; A J Swerdlow
Collaborators, Affiliations
- PMID: 23652303
- PMCID: PMC3681009
- DOI: 10.1038/bjc.2013.219
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors
R Cooke et al. Br J Cancer. 2013.
Abstract
Background: Women treated with supradiaphragmatic radiotherapy (sRT) for Hodgkin lymphoma (HL) at young ages have a substantially increased breast cancer risk. Little is known about how menarcheal and reproductive factors modify this risk.
Methods: We examined the effects of menarcheal age, pregnancy, and menopausal age on breast cancer risk following sRT in case-control data from questionnaires completed by 2497 women from a cohort of 5002 treated with sRT for HL at ages <36 during 1956-2003.
Results: Two-hundred and sixty women had been diagnosed with breast cancer. Breast cancer risk was significantly increased in patients treated within 6 months of menarche (odds ratio (OR) 5.52, 95% confidence interval (CI) (1.97-15.46)), and increased significantly with proximity of sRT to menarche (Ptrend<0.001). It was greatest when sRT was close to a late menarche, but based on small numbers and needing reexamination elsewhere. Risk was not significantly affected by full-term pregnancies before or after treatment. Risk was significantly reduced by early menopause (OR 0.55, 95% CI (0.35-0.85)), and increased with number of premenopausal years after treatment (Ptrend=0.003).
Conclusion: In summary, this paper shows for the first time that sRT close to menarche substantially increases breast cancer risk. Careful consideration should be given to follow-up of these women, and to measures that might reduce their future breast cancer risk.
Similar articles
- Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study.
Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister TA, Lucraft HH, Radford JA, Stevens AM, Syndikus I, Williams MV. Swerdlow AJ, et al. J Clin Oncol. 2012 Aug 1;30(22):2745-52. doi: 10.1200/JCO.2011.38.8835. Epub 2012 Jun 25. J Clin Oncol. 2012. PMID: 22734026 - Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH. Travis LB, et al. J Natl Cancer Inst. 2005 Oct 5;97(19):1428-37. doi: 10.1093/jnci/dji290. J Natl Cancer Inst. 2005. PMID: 16204692 - Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
Krul IM, Opstal-van Winden AWJ, Aleman BMP, Janus CPM, van Eggermond AM, De Bruin ML, Hauptmann M, Krol ADG, Schaapveld M, Broeks A, Kooijman KR, Fase S, Lybeert ML, Zijlstra JM, van der Maazen RWM, Kesminiene A, Diallo I, de Vathaire F, Russell NS, van Leeuwen FE. Krul IM, et al. Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):843-853. doi: 10.1016/j.ijrobp.2017.07.016. Epub 2017 Jul 18. Int J Radiat Oncol Biol Phys. 2017. PMID: 28888722 - Reproductive factors and breast cancer.
Kelsey JL, Gammon MD, John EM. Kelsey JL, et al. Epidemiol Rev. 1993;15(1):36-47. doi: 10.1093/oxfordjournals.epirev.a036115. Epidemiol Rev. 1993. PMID: 8405211 Review. - Postmenopausal hormone replacement in the woman with a reproductive risk factor for breast cancer.
Scheele F, Burger CW, Kenemans P. Scheele F, et al. Maturitas. 1999 Dec 15;33(3):191-6. doi: 10.1016/s0378-5122(99)00083-3. Maturitas. 1999. PMID: 10656497 Review.
Cited by
- Cancer incidence and mortality in 23 000 patients with type 1 diabetes in the UK: Long-term follow-up.
Swerdlow AJ, Jones ME, Slater SD, Burden ACF, Botha JL, Waugh NR, Morris AD, Gatling W, Gillespie KM, Patterson CC, Schoemaker MJ. Swerdlow AJ, et al. Int J Cancer. 2023 Aug 1;153(3):512-523. doi: 10.1002/ijc.34548. Epub 2023 May 15. Int J Cancer. 2023. PMID: 37190903 Free PMC article. - Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's disease.
Ciccarone M, Cavaceppi P, Tesei C, Brunetti S, Pulsoni A, Annibali O, Gasparoli C, Battistini R, Hohaus S, Pelliccia S, Tafuri A, Cox MC, Cantonetti M, Rigacci L, Abruzzese E. Ciccarone M, et al. Front Oncol. 2023 Apr 21;13:1059393. doi: 10.3389/fonc.2023.1059393. eCollection 2023. Front Oncol. 2023. PMID: 37152067 Free PMC article. - Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases.
Yu Y, Shi X, Wang X, Zhang P, Bai O, Li Y. Yu Y, et al. Cell Biosci. 2022 Mar 12;12(1):30. doi: 10.1186/s13578-022-00763-0. Cell Biosci. 2022. PMID: 35279210 Free PMC article. Review. - Breast cancer risk in residents of Belarus exposed to Chernobyl fallout while pregnant or lactating: standardized incidence ratio analysis, 1997 to 2016.
Cahoon EK, Preston D, Zhang R, Vij V, Little MP, Mabuchi K, Drozdovitch V, Chizhov K, Yauseyenka VV, Rozhko AV, Velalkin IV. Cahoon EK, et al. Int J Epidemiol. 2022 May 9;51(2):547-554. doi: 10.1093/ije/dyab226. Int J Epidemiol. 2022. PMID: 34687542 Free PMC article.
References
- Aisenberg AC, Finkelstein DM, Doppke KP, Koerner FC, Boivin JF, Willett CG. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer. 1997;79 (6:1203–1210. - PubMed
- Bean JA, Leeper JD, Wallace RB, Sherman BM, Jagger H. Variations in the reporting of menstrual histories. Am J Epidemiol. 1979;109 (2:181–185. - PubMed
- Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT. Breast cancer and other second neoplasms after childhood Hodgkin's disease. New Engl J Med. 1996;334 (12:745–751. - PubMed
- Breslow NE, Day NE.1980Statistical methods in cancer research. Volume I—The Analysis of Case-Control StudiesInternational Agency for Research on Cancer: Lyon, France - PubMed
- Burrill W, Barber JB, Roberts SA, Bulman B, Scott D. Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay. Int J Radiat Biol. 2000;76 (12:1617–1619. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical